Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Claudia Marchetti, Ludovico Muzii, Alessia Romito & Pierluigi Benedetti Panici. (2019) First-line treatment of women with advanced ovarian cancer: focus on bevacizumab. OncoTargets and Therapy 12, pages 1095-1103.
Read now
Read now
Anji Li, Shuai Sun, Tao Song, Xi Li, Wen Cheng, Ruipin Yao, Danying Zhang, Zailong Cai, Jie Zhang, Dongxia Zhai & Chaoqin Yu. (2018) Targeted therapy and immunotherapy for platinum-refractory advanced ovarian adenosquamous carcinoma: a case report. OncoTargets and Therapy 11, pages 3705-3711.
Read now
Read now
SuYi Yi, LongJia Zeng, Yan Kuang, ZhiJuan Cao, ChengJun Zheng, Yue Zhang, Meng Liao & Lu Yang. (2017) Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis. OncoTargets and Therapy 10, pages 973-984.
Read now
Read now
Articles from other publishers (9)
Mingo M. H. Yung, Michelle K. Y. Siu, Hextan Y. S. Ngan, David W. Chan & Karen K. L. Chan. (2022) Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers. International Journal of Molecular Sciences 23:12, pages 6857.
Crossref
Crossref
Riya Khetan, Cintya Dharmayanti, Todd A. Gillam, Eric Kübler, Manuela Klingler-Hoffmann, Carmela Ricciardelli, Martin K. Oehler, Anton Blencowe, Sanjay Garg & Hugo Albrecht. (2022) Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers 14:10, pages 2362.
Crossref
Crossref
Jonathan A. Panggabean, Sya’ban P. Adiguna, Tutik Murniasih, Siti I. Rahmawati, Asep Bayu & Masteria Y. Putra. (2022) Structure–Activity Relationship of Cytotoxic Natural Products from Indonesian Marine Sponges. Revista Brasileira de Farmacognosia 32:1, pages 12-38.
Crossref
Crossref
Iago Dillion Lima CavalcantiIago Dillion Lima Cavalcanti. 2022. Chemotherapy Protocols and Infusion Sequence. Chemotherapy Protocols and Infusion Sequence
233
266
.
Yanxin Wang, Yi-Shiou Chiou, Qing-Yun Chong, Mengyi Zhang, Kanchuragoppal S. Rangappa, Lan Ma, Tao Zhu, Alan Prem Kumar, Ruby Yun-Ju Huang, Vijay Pandey, Basappa & Peter E. Lobie. (2020) Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior. ACS Pharmacology & Translational Science 3:6, pages 1083-1099.
Crossref
Crossref
Yuan Wang, Guo-Hui Wan, Ying-Min Wu, Hong-Sheng Wang, Hai-Fang Wang, Ge Zhang, Lin-Lin Lu, Zi-Qian Li, Ka-Ying Chan, Yan Zhou, Shao-Hui Cai, Yi-Fei Qi & Jun Du. (2018) AP-1 confers resistance to anti-cancer therapy by activating XIAP. Oncotarget 9:18, pages 14124-14137.
Crossref
Crossref
Hangfei Fu, Nish Vadalia, Eric R. Xue, Candice Johnson, Luqiao Wang, William Y. Yang, Claudette Sanchez, Jun Nelson, Qian Chen, Eric T. Choi, Jian-Xing Ma, Jun Yu, Hong Wang & Xiaofeng Yang. (2017) Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study. Journal of Hematology & Oncology 10:1.
Crossref
Crossref
Yu Shen Wu, Lin Shui, Dan Shen & Xiaopin Chen. (2016) Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials. Oncotarget 8:6, pages 10703-10713.
Crossref
Crossref
Hongying Sui, Caixia Shi, Zhipeng Yan & Mei Wu. (2016) Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer. Oncotarget 7:29, pages 45995-46001.
Crossref
Crossref